BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25980496)

  • 1. miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.
    Stark MS; Bonazzi VF; Boyle GM; Palmer JM; Symmons J; Lanagan CM; Schmidt CW; Herington AC; Ballotti R; Pollock PM; Hayward NK
    Oncotarget; 2015 Jul; 6(19):17753-63. PubMed ID: 25980496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
    Kim JH; Ahn JH; Lee M
    Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.
    Sun X; Li J; Sun Y; Zhang Y; Dong L; Shen C; Yang L; Yang M; Li Y; Shen G; Tu Y; Tao J
    Oncotarget; 2016 Aug; 7(33):53558-53570. PubMed ID: 27448964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-579-3p controls melanoma progression and resistance to target therapy.
    Fattore L; Mancini R; Acunzo M; Romano G; Laganà A; Pisanu ME; Malpicci D; Madonna G; Mallardo D; Capone M; Fulciniti F; Mazzucchelli L; Botti G; Croce CM; Ascierto PA; Ciliberto G
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5005-13. PubMed ID: 27503895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
    Vitiello M; Tuccoli A; D'Aurizio R; Sarti S; Giannecchini L; Lubrano S; Marranci A; Evangelista M; Peppicelli S; Ippolito C; Barravecchia I; Guzzolino E; Montagnani V; Gowen M; Mercoledi E; Mercatanti A; Comelli L; Gurrieri S; Wu LW; Ope O; Flaherty K; Boland GM; Hammond MR; Kwong L; Chiariello M; Stecca B; Zhang G; Salvetti A; Angeloni D; Pitto L; Calorini L; Chiorino G; Pellegrini M; Herlyn M; Osman I; Poliseno L
    Oncotarget; 2017 Apr; 8(15):25395-25417. PubMed ID: 28445987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
    Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
    J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.
    Vergani E; Di Guardo L; Dugo M; Rigoletto S; Tragni G; Ruggeri R; Perrone F; Tamborini E; Gloghini A; Arienti F; Vergani B; Deho P; De Cecco L; Vallacchi V; Frati P; Shahaj E; Villa A; Santinami M; De Braud F; Rivoltini L; Rodolfo M
    Oncotarget; 2016 Jan; 7(4):4428-41. PubMed ID: 26684239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.
    Chai G; Liu N; Ma J; Li H; Oblinger JL; Prahalad AK; Gong M; Chang LS; Wallace M; Muir D; Guha A; Phipps RJ; Hock JM; Yu X
    Cancer Sci; 2010 Sep; 101(9):1997-2004. PubMed ID: 20550523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
    Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
    Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
    Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
    Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
    Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
    Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF
    BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
    Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    Mishra PJ; Mishra PJ; Merlino G
    PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients.
    Behrmann I; Margue C; Kreis S
    EBioMedicine; 2015 Jul; 2(7):625-6. PubMed ID: 26286354
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.
    Lenarduzzi M; Hui AB; Alajez NM; Shi W; Williams J; Yue S; O'Sullivan B; Liu FF
    PLoS One; 2013; 8(1):e53765. PubMed ID: 23335975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
    Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.